2018 Publications

(18)F-Fluorodeoxyglucose positron emission tomography-computed tomography imaging in HIV-infected patients with lymphadenopathy, with or without fever and/or splenomegaly. (2018) Jain, L., S. Mackenzie, J. B. Bomanji, R. Shortman, M. Noursadeghi, S. G. Edwards and R. F. Miller. Int J STD AIDS 29(7): 691-694 https://doi.org/10.1177/0956462417745960.

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis. (2018) Vjecha, M. J., S. Tiberi and A. Zumla. Nat Rev Drug Discov 17(9): 607-608 https://doi.org/10.1038/nrd.2018.28.

Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening. (2018) Melendez, J., L. Hogeweg, C. I. Sanchez, R. Philipsen, R. W. Aldridge, A. C. Hayward, I. Abubakar, B. van Ginneken and A. Story. Int J Tuberc Lung Dis 22(5): 567-571 https://doi.org/10.5588/ijtld.17.0492.

Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era. (2018) Gupta, R. K., M. Lipman, A. Story, A. Hayward, G. de Vries, R. van Hest, C. Erkens, M. X. Rangaka and I. Abubakar. Int J Tuberc Lung Dis 22(5): 479-487 https://doi.org/10.5588/ijtld.17.0767.

Advancing global tuberculosis control after the UNGA-HLM. (2018) Marais, B. and A. Zumla. Lancet 392(10153): 1096-1097 https://doi.org/10.1016/S0140-6736(18)32361-4.

Advancing political will to end the tuberculosis epidemic. (2018) Herbert, N., B. S. Masham, B. A. Suttie, V. Sharma, S. Albani, O. Domenti, R. Flurry, M. Oliver and A. Zumla. Lancet Infect Dis 18(7): 711-712 https://doi.org/10.1016/S1473-3099(17)30679-5.

Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition. (2018) Danquah, C. A., E. Kakagianni, P. Khondkar, A. Maitra, M. Rahman, D. Evangelopoulos, T. D. McHugh, P. Stapleton, J. Malkinson, S. Bhakta and S. Gibbons. Sci Rep 8(1): 1150 https://doi.org/10.1038/s41598-017-18948-w.

Ancient genomes reveal a high diversity of Mycobacterium leprae in medieval Europe. (2018) Schuenemann, V. J., C. Avanzi, B. Krause-Kyora, A. Seitz, A. Herbig, S. Inskip, M. Bonazzi, E. Reiter, C. Urban, D. Dangvard Pedersen, G. M. Taylor, P. Singh, G. R. Stewart, P. Veleminsky, J. Likovsky, A. Marcsik, E. Molnar, G. Palfi, V. Mariotti, A. Riga, M. G. Belcastro, J. L. Boldsen, A. Nebel, S. Mays, H. D. Donoghue, S. Zakrzewski, A. Benjak, K. Nieselt, S. T. Cole and J. Krause. PLoS Pathog 14(5): e1006997 https://doi.org/10.1371/journal.ppat.1006997.

B cells or T cells in TB: a continuing conundrum. (2018) Maeurer, M., M. Rao and A. Zumla. Lancet Respir Med 6(4): 237-238 https://doi.org/10.1016/S2213-2600(18)30080-8.

Burden of tuberculosis in HIV-positive pregnant women in Cape Town, South Africa. (2018) Odayar, J., M. X. Rangaka, A. Zerbe, G. Petro, J. A. McIntyre, T. K. Phillips, E. J. Abrams and L. Myer. Int J Tuberc Lung Dis 22(7): 760-765 https://doi.org/10.5588/ijtld.17.0448.

Case Report: Three's a crowd: a case report examining the diagnostic and pharmacokinetic challenges in HIV-tuberculous meningitis-malaria co-infection. (2018) Ellis, J., P. C. Eneh, K. Ssebambulidde, M. K. Rutakingirwa, M. Lamorde, J. Rhein, F. V. Cresswell, D. R. Boulware and M. R. Nicol. Wellcome Open Res 3: 111 https://doi.org/10.12688/wellcomeopenres.14726.2.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial. (2018) Post, F. A., A. J. Szubert, A. J. Prendergast, V. Johnston, H. Lyall, F. Fitzgerald, V. Musiime, G. Musoro, P. Chepkorir, C. Agutu, J. Mallewa, C. Rajapakse, H. Wilkes, J. Hakim, P. Mugyenyi, A. S. Walker, D. M. Gibb, S. L. Pett, E. m. i. H. I. V. i. a. Reduction of and T. children starting antiretroviral therapy Trial. Clin Infect Dis 66(suppl_2): S132-S139 https://doi.org/10.1093/cid/cix1141.

Cell-wall synthesis and ribosome maturation are co-regulated by an RNA switch in Mycobacterium tuberculosis. (2018) Schwenk, S., A. Moores, I. Nobeli, T. D. McHugh and K. B. Arnvig. Nucleic Acids Res 46(11): 5837-5849 https://doi.org/10.1093/nar/gky226.

The challenge of estimating tuberculosis mortality accurately in England and Wales. (2018) Lalor, M. K., T. Mohiyuddin, T. Uddin, H. L. Thomas, M. Lipman and C. N. J. Campbell. Int J Tuberc Lung Dis 22(5): 572-578 https://doi.org/10.5588/ijtld.17.0695.

Clinical perspectives into the use of thalidomide for central nervous system tuberculosis. (2018) Keddie, S., V. Bharambe, A. Jayakumar, A. Shah, V. Sanchez, A. Adams and S. Gnanapavan. Eur J Neurol 25(11): 1345-1351 https://doi.org/10.1111/ene.13732.

Community perceptions of the socio-economic structural context influencing HIV and TB risk, prevention and treatment in a high prevalence area in the era of antiretroviral therapy. (2018) Ngwenya, N., D. Gumede, M. Shahmanesh, N. McGrath, A. Grant and J. Seeley. Afr J AIDS Res 17(1): 72-81 https://doi.org/10.2989/16085906.2017.1415214.

Comparing different technologies for active TB case-finding among the homeless: a transmission-dynamic modelling study. (2018) Mugwagwa, T., H. R. Stagg, I. Abubakar and P. J. White. Sci Rep 8(1): 1433 https://doi.org/10.1038/s41598-018-19757-5.

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. (2018) Fregonese, F., S. D. Ahuja, O. W. Akkerman, D. Arakaki-Sanchez, I. Ayakaka, P. Baghaei, D. Bang, M. Bastos, A. Benedetti, M. Bonnet, A. Cattamanchi, P. Cegielski, J. Y. Chien, H. Cox, M. Dedicoat, C. Erkens, P. Escalante, D. Falzon, A. J. Garcia-Prats, M. Gegia, S. H. Gillespie, J. R. Glynn, S. Goldberg, D. Griffith, K. R. Jacobson, J. C. Johnston, E. C. Jones-Lopez, A. Khan, W. J. Koh, A. Kritski, Z. Y. Lan, J. H. Lee, P. Z. Li, E. L. Maciel, R. M. Galliez, C. S. C. Merle, M. Munang, G. Narendran, V. N. Nguyen, A. Nunn, A. Ohkado, J. S. Park, P. P. J. Phillips, C. Ponnuraja, R. Reves, K. Romanowski, K. Seung, H. S. Schaaf, A. Skrahina, D. V. Soolingen, P. Tabarsi, A. Trajman, L. Trieu, V. V. Banurekha, P. Viiklepp, J. Y. Wang, T. Yoshiyama and D. Menzies. Lancet Respir Med 6(4): 265-275 https://doi.org/10.1016/S2213-2600(18)30078-X.

Concrete action now: UN High-Level Meeting on Tuberculosis. (2018) Herbert, N., V. Sharma, B. S. Masham, B. S. Sheehan, J. Hauser and A. Zumla. Lancet Infect Dis 18(7): 709-710 https://doi.org/10.1016/S1473-3099(18)30171-3.

Corticosteroids as an adjunct to tuberculosis therapy. (2018) Schutz, C., A. G. Davis, B. Sossen, R. P. Lai, M. Ntsekhe, Y. X. Harley and R. J. Wilkinson. Expert Rev Respir Med 12(10): 881-891 https://doi.org/10.1080/17476348.2018.1515628.

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study. (2018) Mendelson, F., R. Griesel, N. Tiffin, M. Rangaka, A. Boulle, M. Mendelson and G. Maartens. BMC Infect Dis 18(1): 399 https://doi.org/10.1186/s12879-018-3303-6.

Creating a web-based electronic tool to aid tuberculosis (TB) cluster investigation: data integration in TB surveillance activities in the United Kingdom, 2013 to 2016. (2018) Davidson, J. A., L. F. Anderson, V. Adebisi, L. de Jongh, A. Burkitt and M. K. Lalor. Euro Surveill 23(44) https://doi.org/10.2807/1560-7917.ES.2018.23.44.1700794.

The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control. (2018) Otu, A., M. Hashmi, A. M. Mukhtar, A. Kwizera, S. Tiberi, B. Macrae, A. Zumla, M. W. Dunser and M. Mer. J Crit Care 45: 184-196 https://doi.org/10.1016/j.jcrc.2018.03.015.

Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults. (2018) Ellis, J., F. V. Cresswell, J. Rhein, K. Ssebambulidde and D. R. Boulware. Open Forum Infect Dis 5(8): ofy193 https://doi.org/10.1093/ofid/ofy193.

Cytokine diagnosis of pleural TB: will it stand the test of time? (2018) Tebruegge, M. and P. T. Elkington. Thorax 73(3): 206-207 https://doi.org/10.1136/thoraxjnl-2017-210918.

Data in TB have to be both big and good. (2018) Tweed, C. and A. Nunn. Int J Tuberc Lung Dis 22(5): 476 https://doi.org/10.5588/ijtld.18.0200.

Determinants of non-adherence to treatment for tuberculosis in high-income and middle-income settings: a systematic review protocol. (2018) Wurie, F. B., V. Cooper, R. Horne and A. C. Hayward. BMJ Open 8(1): e019287 https://doi.org/10.1136/bmjopen-2017-019287.

Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization's algorithm for seriously ill HIV-infected patients. (2018) Maartens, G., A. Stewart, R. Griesel, A. P. Kengne, F. Dube, M. Nicol, M. X. Rangaka and M. Mendelson. South Afr J HIV Med 19(1): 851 https://doi.org/10.4102/sajhivmed.v19i1.851.

Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design. (2018) Petkar, K. C., S. Chavhan, N. Kunda, I. Saleem, S. Somavarapu, K. M. G. Taylor and K. K. Sawant. AAPS PharmSciTech 19(4): 1758-1772 https://doi.org/10.1208/s12249-018-0972-9.

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. (2018) Caro-Vega, Y., A. Schultze, W. E. AM, F. A. Post, A. Panteleev, A. Skrahin, J. M. Miro, E. Girardi, D. N. Podlekareva, J. D. Lundgren, J. Sierra-Madero, J. Toibaro, J. Andrade-Villanueva, S. Tetradov, J. Fehr, J. Cayla, M. H. Losso, R. F. Miller, A. Mocroft, O. Kirk and B. Crabtree-Ramirez. BMC Infect Dis 18(1): 191 https://doi.org/10.1186/s12879-018-3077-x.

Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood. (2018) Lowe, D. M., J. Demaret, N. Bangani, J. K. Nakiwala, R. Goliath, K. A. Wilkinson, R. J. Wilkinson and A. R. Martineau. Front Immunol 9: 903 https://doi.org/10.3389/fimmu.2018.00903.

Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. (2018) Doyle, R. M., C. Burgess, R. Williams, R. Gorton, H. Booth, J. Brown, J. M. Bryant, J. Chan, D. Creer, J. Holdstock, H. Kunst, S. Lozewicz, G. Platt, E. Y. Romero, G. Speight, S. Tiberi, I. Abubakar, M. Lipman, T. D. McHugh and J. Breuer. J Clin Microbiol 56(8) https://doi.org/10.1128/JCM.00666-18.

Does being on TB treatment predict a higher burden of problems and concerns among HIV outpatients in Kenya? a cross-sectional self-report study. (2018) Nkhoma, K., A. Ahmed, Z. Ali, N. Gikaara, L. Sherr and R. Harding. AIDS Care 30(sup2): 28-32 https://doi.org/10.1080/09540121.2018.1469726.

The duration of protection of school-aged BCG vaccination in England: a population-based case-control study. (2018) Mangtani, P., P. Nguipdop-Djomo, R. H. Keogh, J. A. C. Sterne, I. Abubakar, P. G. Smith, P. E. M. Fine, E. Vynnycky, J. M. Watson, D. Elliman, M. Lipman and L. C. Rodrigues. Int J Epidemiol 47(1): 193-201 https://doi.org/10.1093/ije/dyx141.

Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis. (2018) Guardia, A., J. Baiget, M. Cacho, A. Perez, M. Ortega-Guerra, W. Nxumalo, S. D. Khanye, J. Rullas, F. Ortega, E. Jimenez, E. Perez-Herran, M. T. Fraile-Gabaldon, J. Esquivias, R. Fernandez, E. Porras-De Francisco, L. Encinas, M. Alonso, I. Giordano, C. Rivero, J. Miguel-Siles, J. G. Osende, K. A. Badiola, P. J. Rutledge, M. H. Todd, M. Remuinan and C. Alemparte. J Med Chem 61(24): 11327-11340 https://doi.org/10.1021/acs.jmedchem.8b01533.

Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis. (2018) Tomkins-Netzer, O., B. C. S. Leong, X. Zhang, S. Lightman, P. J. McCluskey and T. B. S. G. Sydney-London Latent Ocular. Am J Ophthalmol 190: 164-170 https://doi.org/10.1016/j.ajo.2018.03.032.

Effect of the Number of Pregnancies on Mortality Risk in HIV-Infected Women: a Prospective Cohort Study in Rural KwaZulu-Natal, South Africa. (2018) Yoo, H., J. Lee, J. J. Yim, T. Barnighausen, F. Tanser and S. K. Park. AIDS Behav 22(12): 3971-3980 https://doi.org/10.1007/s10461-018-2232-0.

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. (2018) Greenaway, C., M. Pareek, C. N. Abou Chakra, M. Walji, I. Makarenko, B. Alabdulkarim, C. Hogan, T. McConnell, B. Scarfo, R. Christensen, A. Tran, N. Rowbotham, T. Noori, M. J. van der Werf, K. Pottie, A. Matteelli, D. Zenner and R. L. Morton. Euro Surveill 23(14) https://doi.org/10.2807/1560-7917.ES.2018.23.14.17-00542.

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review. (2018) Greenaway, C., M. Pareek, C. N. Abou Chakra, M. Walji, I. Makarenko, B. Alabdulkarim, C. Hogan, T. McConnell, B. Scarfo, R. Christensen, A. Tran, N. Rowbotham, M. J. van der Werf, T. Noori, K. Pottie, A. Matteelli, D. Zenner and R. L. Morton. Euro Surveill 23(14) https://doi.org/10.2807/1560-7917.ES.2018.23.14.17-00543.

Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review. (2018) Heuvelings, C. C., P. F. Greve, S. G. de Vries, B. J. Visser, S. Belard, S. Janssen, A. L. Cremers, R. Spijker, E. Shaw, R. A. Hill, A. Zumla, A. Sandgren, M. J. van der Werf and M. P. Grobusch. BMJ Open 8(9): e019642 https://doi.org/10.1136/bmjopen-2017-019642.

Eliminating tuberculosis in low-burden countries. (2018) Jackson, C., T. Cohen, M. X. Rangaka and I. Abubakar. Int J Tuberc Lung Dis 22(1): 3 https://doi.org/10.5588/ijtld.17.0707.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update. (2018) Migliori, G. B., G. Sotgiu, S. Rosales-Klintz, R. Centis, L. D'Ambrosio, I. Abubakar, G. Bothamley, J. A. Caminero, D. M. Cirillo, M. Dara, G. de Vries, S. Aliberti, A. T. Dinh-Xuan, R. Duarte, F. Midulla, I. Solovic, D. R. Subotic, M. Amicosante, A. M. Correia, A. Cirule, G. Gualano, H. Kunst, F. Palmieri, V. Riekstina, S. Tiberi, R. Verduin and M. J. van der Werf. Eur Respir J 51(5) https://doi.org/10.1183/13993003.02678-2017.

An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. (2018) Kik, S. V., S. Schumacher, D. M. Cirillo, G. Churchyard, C. Boehme, D. Goletti, M. X. Rangaka, C. M. Denkinger, C. Lienhardt, C. Gilpin, A. Matteelli and F. Cobelens. Eur Respir J 52(4) https://doi.org/10.1183/13993003.00946-2018.

Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis. (2018) Rao, M., D. Valentini, A. Zumla and M. Maeurer. Int J Infect Dis 69: 78-84 https://doi.org/10.1016/j.ijid.2018.02.021.

From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the Clinic. (2018) Balloux, F., O. Bronstad Brynildsrud, L. van Dorp, L. P. Shaw, H. Chen, K. A. Harris, H. Wang and V. Eldholm. Trends Microbiol 26(12): 1035-1048 https://doi.org/10.1016/j.tim.2018.08.004

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study. (2018) Murphy, M. E., G. H. Wills, S. Murthy, C. Louw, A. L. C. Bateson, R. D. Hunt, T. D. McHugh, A. J. Nunn, S. K. Meredith, C. M. Mendel, M. Spigelman, A. M. Crook, S. H. Gillespie and R. E. consortium. BMC Med 16(1): 189 https://doi.org/10.1186/s12916-018-1169-5.

Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. (2018) Tylee, D. S., J. Sun, J. L. Hess, M. A. Tahir, E. Sharma, R. Malik, B. B. Worrall, A. J. Levine, J. J. Martinson, S. Nejentsev, D. Speed, A. Fischer, E. Mick, B. R. Walker, A. Crawford, S. F. A. Grant, C. Polychronakos, J. P. Bradfield, P. M. A. Sleiman, H. Hakonarson, E. Ellinghaus, J. T. Elder, L. C. Tsoi, R. C. Trembath, J. N. Barker, A. Franke, A. Dehghan, T. Me Research, C. C. Inflammation Working Group of the, M. C. o. t. I. S. G. Consortium, R. Netherlands Twin, C. W. G. neuro, C. Obsessive, C. Tourette Syndrome Working Group of the Psychiatric Genomics, S. V. Faraone and S. J. Glatt. Am J Med Genet B Neuropsychiatr Genet 177(7): 641-657 https://doi.org/10.1002/ajmg.b.32652.

Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation. (2018) Brynildsrud, O. B., C. S. Pepperell, P. Suffys, L. Grandjean, J. Monteserin, N. Debech, J. Bohlin, K. Alfsnes, J. O. Pettersson, I. Kirkeleite, F. Fandinho, M. A. da Silva, J. Perdigao, I. Portugal, M. Viveiros, T. Clark, M. Caws, S. Dunstan, P. V. K. Thai, B. Lopez, V. Ritacco, A. Kitchen, T. S. Brown, D. van Soolingen, M. B. O'Neill, K. E. Holt, E. J. Feil, B. Mathema, F. Balloux and V. Eldholm. Sci Adv 4(10): eaat5869 https://doi.org/10.1126/sciadv.aat5869.

The Global Fund links with Lombard Odier bank. (2018) Costello, A. Lancet 391(10131): 1674-1675 https://doi.org/10.1016/S0140-6736(18)30772-4.

The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. (2018) Floyd, K., P. Glaziou, A. Zumla and M. Raviglione. Lancet Respir Med 6(4): 299-314 https://doi.org/10.1016/S2213-2600(18)30057-2.

High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis. (2018) Zelmer, A., L. Stockdale, S. A. Prabowo, F. Cia, N. Spink, M. Gibb, A. Eddaoudi and H. A. Fletcher. F1000Res 7: 296 https://doi.org/10.12688/f1000research.14239.2.

High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. (2018) Diel, R., M. Lipman and W. Hoefsloot. BMC Infect Dis 18(1): 206 https://doi.org/10.1186/s12879-018-3113-x.

High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population. (2018) Aldridge, R. W., A. C. Hayward, S. Hemming, S. K. Yates, G. Ferenando, L. Possas, E. Garber, J. M. Watson, A. M. Geretti, T. D. McHugh, M. Lipman and A. Story. Thorax 73(6): 557-564 https://doi.org/10.1136/thoraxjnl-2016-209579.

The historic and unprecedented United Nations General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB)-'United to End TB: An Urgent Global Response to a Global Epidemic'. (2018) Zumla, A. and E. Petersen. Int J Infect Dis 75: 118-120 https://doi.org/10.1016/j.ijid.2018.09.017.

Household-Contact Investigation for Detection of Tuberculosis in Vietnam. (2018) Yates, T. A. N Engl J Med 378(22): 2140-2141 https://doi.org/10.1056/NEJMc1804977.

Identification of mycolic acid forms using surface-enhanced Raman scattering as a fast detection method for tuberculosis. (2018) Perumal, J., U. S. Dinish, A. K. Bendt, A. Kazakeviciute, C. Y. Fu, I. L. H. Ong and M. Olivo. Int J Nanomedicine 13: 6029-6038 https://doi.org/10.2147/IJN.S171400.

Identifying mixed Mycobacterium tuberculosis infections from whole genome sequence data. (2018) Sobkowiak, B., J. R. Glynn, R. Houben, K. Mallard, J. E. Phelan, J. A. Guerra-Assuncao, L. Banda, T. Mzembe, M. Viveiros, R. McNerney, J. Parkhill, A. C. Crampin and T. G. Clark. BMC Genomics 19(1): 613 https://doi.org/10.1186/s12864-018-4988-z.

Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review. (2018) Olaru, I. D., H. Albert, J. Zallet, U. E. Werner, N. Ahmed, H. L. Rieder, M. Salfinger and K. Kranzer. Int J Tuberc Lung Dis 22(3): 309-320 https://doi.org/10.5588/ijtld.17.0629.

The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis. (2018) Adamu, A. L., M. H. Aliyu, N. A. Galadanci, B. M. Musa, U. M. Lawan, U. Bashir and I. Abubakar. Int J Equity Health 17(1): 4 https://doi.org/10.1186/s12939-017-0714-8.

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants. (2018) Zumla, A. and I. Abubakar. BMC Med 16(1): 221 https://doi.org/10.1186/s12916-018-1218-0.

Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. (2018) Peloquin, C. A., P. P. J. Phillips, C. D. Mitnick, K. Eisenach, R. F. Patientia, L. Lecca, E. Gotuzzo, N. R. Gandhi, D. Butler, A. H. Diacon, B. Martel, J. Santillan, K. R. Hunt, D. Vargas, F. von Groote-Bidlingmaier, C. Seas, N. Dianis, A. Moreno-Martinez, P. Kaur and C. R. Horsburgh, Jr. Antimicrob Agents Chemother 62(10) https://doi.org/10.1128/AAC.00770-18.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. (2018) Pettit, A. C., M. J. Giganti, S. M. Ingle, M. T. May, B. E. Shepherd, M. J. Gill, G. Fatkenheuer, S. Abgrall, M. S. Saag, J. Del Amo, A. C. Justice, J. M. Miro, M. Cavasinni, F. Dabis, A. D. Monforte, P. Reiss, J. Guest, D. Moore, L. Shepherd, N. Obel, H. M. Crane, C. Smith, R. Teira, R. Zangerle, J. A. Sterne, T. R. Sterling and i. Antiretroviral Therapy Cohort Collaboration. J Int AIDS Soc 21(1) https://doi.org/10.1002/jia2.25031.

Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users. (2018) Oprea, C., I. Ianache, P. I. Calistru, M. Nica, S. Ruta, C. Smith and M. Lipman. HIV Med 19(5): 316-323 https://doi.org/10.1111/hiv.12576.

Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study. (2018) Crawshaw, A. F., M. Pareek, J. Were, S. Schillinger, O. Gorbacheva, K. P. Wickramage, S. Mandal, V. Delpech, N. Gill, H. Kirkbride and D. Zenner. BMC Med 16(1): 143 https://doi.org/10.1186/s12916-018-1125-4.

Integrin alpha2beta1 Expression Regulates Matrix Metalloproteinase-1-Dependent Bronchial Epithelial Repair in Pulmonary Tuberculosis. (2018) Brilha, S., D. L. W. Chong, A. A. Khawaja, C. W. M. Ong, N. J. Guppy, J. C. Porter and J. S. Friedland. Front Immunol 9: 1348 https://doi.org/10.3389/fimmu.2018.01348.

Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach. (2018) Ali, M. T., N. Blicharska, J. A. Shilpi and V. Seidel. Sci Rep 8(1): 12238 https://doi.org/10.1038/s41598-018-30209-y.

Laryngeal tuberculosis: a rare cause of critical airway obstruction. (2018) Cole, A. E., D. Heaton and A. Chekairi. BMJ Case Rep 2018 https://doi.org/10.1136/bcr-2017-222841.

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). (2018) Seddon, J. A., A. J. Garcia-Prats, S. E. Purchase, M. Osman, A. M. Demers, G. Hoddinott, A. M. Crook, E. Owen-Powell, M. J. Thomason, A. Turkova, D. M. Gibb, L. Fairlie, N. Martinson, H. S. Schaaf and A. C. Hesseling. Trials 19(1): 693 https://doi.org/10.1186/s13063-018-3070-0.

Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient. (2018) Mer, M., A. Zumla and M. W. Dunser. Intensive Care Med 44(12): 2229-2231 https://doi.org/10.1007/s00134-018-5161-5.

Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study. (2018) Tweed, C. D., G. H. Wills, A. M. Crook, R. Dawson, A. H. Diacon, C. E. Louw, T. D. McHugh, C. Mendel, S. Meredith, L. Mohapi, M. E. Murphy, S. Murray, S. Murthy, A. J. Nunn, P. P. J. Phillips, K. Singh, M. Spigelman and S. H. Gillespie. BMC Med 16(1): 46 https://doi.org/10.1186/s12916-018-1033-7.

LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages. (2018) Hartlova, A., S. Herbst, J. Peltier, A. Rodgers, O. Bilkei-Gorzo, A. Fearns, B. D. Dill, H. Lee, R. Flynn, S. A. Cowley, P. Davies, P. A. Lewis, I. G. Ganley, J. Martinez, D. R. Alessi, A. D. Reith, M. Trost and M. G. Gutierrez. EMBO J 37(12) https://doi.org/10.15252/embj.201798694.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study. (2018) Efsen, A. M. W., A. Schultze, R. F. Miller, A. Panteleev, A. Skrahin, D. N. Podlekareva, J. M. Miro, E. Girardi, H. Furrer, M. H. Losso, J. Toibaro, J. A. Cayla, A. Mocroft, J. D. Lundgren, F. A. Post, O. Kirk and T. H. s. i. EuroCoord. J Infect 76(1): 44-54 https://doi.org/10.1016/j.jinf.2017.10.007.

Missed opportunities for tuberculosis prevention among patients accessing a UK HIV service. (2018) Rickman, H. M., R. F. Miller, S. Morris-Jones, L. Kellgren, S. G. Edwards and A. D. Grant. Int J STD AIDS 29(12): 1234-1237 https://doi.org/10.1177/0956462418773010.

Mobile phone-based evaluation of latent tuberculosis infection: Proof of concept for an integrated image capture and analysis system. (2018) Naraghi, S., T. Mutsvangwa, R. Goliath, M. X. Rangaka and T. S. Douglas. Comput Biol Med 98: 76-84 https://doi.org/10.1016/j.compbiomed.2018.05.009.

Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. (2018) Aldridge, R. W., A. Story, S. W. Hwang, M. Nordentoft, S. A. Luchenski, G. Hartwell, E. J. Tweed, D. Lewer, S. Vittal Katikireddi and A. C. Hayward. Lancet 391(10117): 241-250 https://doi.org/10.1016/S0140-6736(17)31869-X.

Multitype violence exposures and adolescent antiretroviral nonadherence in South Africa. (2018) Cluver, L., F. Meinck, E. Toska, F. M. Orkin, R. Hodes and L. Sherr. AIDS 32(8): 975-983 https://doi.org/10.1097/QAD.0000000000001795.

Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases. (2018) Scriven, J. E., A. Scobie, N. Q. Verlander, A. Houston, T. Collyns, V. Cajic, O. M. Kon, T. Mitchell, O. Rahama, A. Robinson, S. Withama, P. Wilson, D. Maxwell, D. Agranoff, E. Davies, M. Llewelyn, S. S. Soo, A. Sahota, M. A. Cooper, M. Hunter, J. Tomlins, S. Tiberi, S. Kendall, M. Dedicoat, E. Alexander, T. Fenech, M. Zambon, T. Lamagni, E. G. Smith and M. Chand. Clin Microbiol Infect 24(11): 1164-1170 https://doi.org/10.1016/j.cmi.2018.04.027.

Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential? (2018) Satta, G., M. Lipman, G. P. Smith, C. Arnold, O. M. Kon and T. D. McHugh. Clin Microbiol Infect 24(6): 604-609 https://doi.org/10.1016/j.cmi.2017.10.030.

National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area. (2018) Loutet, M. G., M. Burman, N. Jayasekera, D. Trathen, S. Dart, H. Kunst and D. Zenner. Eur Respir J 51(1) https://doi.org/10.1183/13993003.01226-2017.

Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome. (2018) Nakiwala, J. K., N. F. Walker, C. R. Diedrich, W. Worodria, G. Meintjes, R. J. Wilkinson, H. Mayanja-Kizza, R. Colebunders, L. Kestens, K. A. Wilkinson and D. M. Lowe. J Acquir Immune Defic Syndr 77(2): 221-229 https://doi.org/10.1097/QAI.0000000000001582.

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. (2018) Silva, D. R., M. Dalcolmo, S. Tiberi, M. A. Arbex, M. Munoz-Torrico, R. Duarte, L. D'Ambrosio, D. Visca, A. Rendon, M. Gaga, A. Zumla and G. B. Migliori. J Bras Pneumol 44(2): 153-160 https://doi.org/10.1590/s1806-37562017000000436.

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV. (2018) Ford, D., R. Turner, A. Turkova, M. Penazzato, V. Musiime, M. Bwakura-Dangarembizi, A. Violari, C. Chabala, T. Puthanakit, T. Sudjaritruk, T. R. Cressey, M. Lallemant and D. M. Gibb. J Acquir Immune Defic Syndr 78 Suppl 1: S40-S48 https://doi.org/10.1097/QAI.0000000000001748.

Optimizing Tuberculosis Diagnosis in Human Immunodeficiency Virus-Infected Inpatients Meeting the Criteria of Seriously Ill in the World Health Organization Algorithm. (2018) Griesel, R., A. Stewart, H. van der Plas, W. Sikhondze, M. X. Rangaka, M. P. Nicol, A. P. Kengne, M. Mendelson and G. Maartens. Clin Infect Dis 66(9): 1419-1426 https://doi.org/10.1093/cid/cix988.

Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life. (2018) Bamford, A., A. Turkova, H. Lyall, C. Foster, N. Klein, D. Bastiaans, D. Burger, S. Bernadi, K. Butler, E. Chiappini, P. Clayden, M. Della Negra, V. Giacomet, C. Giaquinto, D. Gibb, L. Galli, M. Hainaut, M. Koros, L. Marques, E. Nastouli, T. Niehues, A. Noguera-Julian, P. Rojo, C. Rudin, H. J. Scherpbier, G. Tudor-Williams and S. B. Welch. HIV Med 19(1): e1-e42 https://doi.org/10.1111/hiv.12217.

Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. (2018) Bell, L. C. K. and M. Noursadeghi. Nat Rev Microbiol 16(2): 80-90 https://doi.org/10.1038/nrmicro.2017.128.

Performance of tuberculin skin tests and interferon-gamma release assays in children younger than 5 years. (2018) Velasco-Arnaiz, E., A. Soriano-Arandes, I. Latorre, N. Altet, J. Dominguez, C. Fortuny, M. Monsonis, M. Tebruegge and A. Noguera-Julian. Pediatr Infect Dis J 37(12): 1235-1241 https://doi.org/10.1097/INF.0000000000002015.

Platelets regulate pulmonary inflammation and tissue destruction in tuberculosis. (2018) Fox, K. A., D. E. Kirwan, A. M. Whittington, N. Krishnan, B. D. Robertson, R. H. Gilman, J. W. Lopez, S. Singh, J. C. Porter and J. S. Friedland. Am J Respir Crit Care Med 198(2): 245-255 https://doi.org/10.1164/rccm.201710-2102OC.

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis. (2018) Murthy, S. E., F. Chatterjee, A. Crook, R. Dawson, C. Mendel, M. E. Murphy, S. R. Murray, A. J. Nunn, P. P. J. Phillips, K. P. Singh, T. D. McHugh, S. H. Gillespie and R. E. Consortium. BMC Med 16(1): 73 https://doi.org/10.1186/s12916-018-1053-3.

Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. (2018) Abubakar, I., F. Drobniewski, J. Southern, A. J. Sitch, C. Jackson, M. Lipman, J. J. Deeks, C. Griffiths, G. Bothamley, W. Lynn, H. Burgess, B. Mann, A. Imran, S. Sridhar, C. Y. Tsou, V. Nikolayevskyy, M. Rees-Roberts, H. Whitworth, O. M. Kon, P. Haldar, H. Kunst, S. Anderson, A. Hayward, J. M. Watson, H. Milburn, A. Lalvani and P. S. Team. Lancet Infect Dis 18(10): 1077-1087 https://doi.org/10.1016/S1473-3099(18)30355-4.

Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. (2018) Menzies, N. A., E. Wolf, D. Connors, M. Bellerose, A. N. Sbarra, T. Cohen, A. N. Hill, R. Yaesoubi, K. Galer, P. J. White, I. Abubakar and J. A. Salomon. Lancet Infect Dis 18(8): e228-e238 https://doi.org/10.1016/S1473-3099(18)30134-8.

A public health approach to palliative care in the response to drug resistant TB: an ethnographic study in Bengaluru, India. (2018) Sawyer, J. M., R. Asgr, F. N. Todd Fordham and J. D. H. Porter. BMC Palliat Care 17(1): 120 https://doi.org/10.1186/s12904-018-0374-5.

Reduction in tuberculosis incidence in the UK from 2011 to 2015: a population-based study. (2018) Thomas, H. L., R. J. Harris, M. C. Muzyamba, J. A. Davidson, M. K. Lalor, C. N. J. Campbell, S. R. Anderson and D. Zenner. Thorax 73(8): 769-775 https://doi.org/10.1136/thoraxjnl-2017-211074.

Regulatory RNA in Mycobacterium tuberculosis, back to basics. (2018) Schwenk, S. and K. B. Arnvig. Pathog Dis 76(4) https://doi.org/10.1093/femspd/fty035.

Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency. (2018) Sperlich, J. M., B. Grimbacher, S. Workman, T. Haque, S. L. Seneviratne, S. O. Burns, V. Reiser, W. Vach, J. R. Hurst and D. M. Lowe. J Allergy Clin Immunol Pract 6(1): 159-168 e153 https://doi.org/10.1016/j.jaip.2017.05.024.

Rethinking non-inferiority: a practical trial design for optimising treatment duration. (2018) Quartagno, M., A. S. Walker, J. R. Carpenter, P. P. Phillips and M. K. Parmar. Clin Trials 15(5): 477-488 https://doi.org/10.1177/1740774518778027.

Seasonal variation in the performance of QuantiFERON-TB Gold In-Tube assays used for the diagnosis of tuberculosis infection. (2018) Tebruegge, M., N. Curtis, V. Clifford, C. Fernandez-Turienzo, N. Klein, K. Fidler, S. Mansour, P. Elkington and S. Morris-Jones. Tuberculosis (Edinb) 110: 26-29 https://doi.org/10.1016/j.tube.2018.03.002.

Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial. (2018) Chabala, C., A. Turkova, M. J. Thomason, E. Wobudeya, S. Hissar, V. Mave, M. van der Zalm, M. Palmer, M. Kapasa, P. K. Bhavani, S. Balaji, P. A. Raichur, A. M. Demers, G. Hoddinott, E. Owen-Powell, A. Kinikar, P. Musoke, V. Mulenga, R. Aarnoutse, H. McIlleron, A. Hesseling, A. M. Crook, M. Cotton, D. M. Gibb and S. t. team. Trials 19(1): 237 https://doi.org/10.1186/s13063-018-2608-5.

Socio-economic gradients in prevalent tuberculosis in Zambia and the Western Cape of South Africa. (2018) Yates, T. A., H. Ayles, F. P. Leacy, A. Schaap, D. Boccia, N. Beyers, P. Godfrey-Faussett and S. Floyd. Trop Med Int Health 23(4): 375-390 https://doi.org/10.1111/tmi.13038.

Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration. (2018) Keating, A. V., J. Soto, C. Tuleu, C. Forbes, M. Zhao and D. Q. M. Craig. Int J Pharm 536(2): 536-546 https://doi.org/10.1016/j.ijpharm.2017.07.008.

Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015. (2018) Smith, C. M., R. Lessells, A. D. Grant, K. Herbst and F. Tanser. Int J Tuberc Lung Dis 22(3): 287-293 https://doi.org/10.5588/ijtld.17.0457.

A suction blister protocol to study human t-cell recall responses in vivo. (2018) Holm, L. L., M. Vukmanovic-Stejic, T. Blauenfeldt, T. Benfield, P. Andersen, A. N. Akbar and M. Ruhwald. J Vis Exp(138) https://doi.org/10.3791/57554.

The surgical management of non-malignant aerodigestive fistula. (2018) Qureshi, Y. A., M. Muntzer Mughal, S. R. Markar, B. Mohammadi, J. George, M. Hayward and D. Lawrence. J Cardiothorac Surg 13(1): 113 https://doi.org/10.1186/s13019-018-0799-1.

Sustainable Survival for adolescents living with HIV: do SDG-aligned provisions reduce potential mortality risk? (2018) Cluver, L., M. Pantelic, M. Orkin, E. Toska, S. Medley and L. Sherr. J Int AIDS Soc 21 Suppl 1 https://doi.org/10.1002/jia2.25056.

Tissue metabolic changes drive cytokine responses to Mycobacterium tuberculosis. (2018) Lachmandas, E., A. B. Rios-Miguel, V. Koeken, E. van der Pasch, V. Kumar, V. Matzaraki, Y. Li, M. Oosting, L. A. B. Joosten, R. A. Notebaart, M. Noursadeghi, M. G. Netea, R. van Crevel and G. Pollara. J Infect Dis 218(1): 165-170 https://doi.org/10.1093/infdis/jiy173.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium. (2018) Abubakar, I., A. Matteelli, G. de Vries, D. Zenner, D. M. Cirillo, K. Lonnroth, G. Popescu, L. Barcellini, A. Story and G. B. Migliori. Eur Respir J 51(5) https://doi.org/10.1183/13993003.02604-2017.

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study. (2018) Tweed, C. D., A. M. Crook, E. I. Amukoye, R. Dawson, A. H. Diacon, M. Hanekom, T. D. McHugh, C. M. Mendel, S. K. Meredith, M. E. Murphy, S. E. Murthy, A. J. Nunn, P. P. J. Phillips, K. P. Singh, M. Spigelman, G. H. Wills and S. H. Gillespie. BMC Infect Dis 18(1): 317 https://doi.org/10.1186/s12879-018-3230-6.

Transmission events revealed in tuberculosis contact investigations in London. (2018) Cavany, S. M., E. Vynnycky, T. Sumner, N. Macdonald, H. L. Thomas, J. White, R. G. White, H. Maguire and C. Anderson. Sci Rep 8(1): 6676 https://doi.org/10.1038/s41598-018-25149-6.

Treating young children co-infected with tuberculosis and HIV. (2018) Turkova, A. and A. Bamford. Lancet HIV https://doi.org/10.1016/S2352-3018(18)30326-6.

Treatment of tuberculous meningitis and its complications in adults. (2018) Davis, A., G. Meintjes and R. J. Wilkinson. Curr Treat Options Neurol 20(3): 5 https://doi.org/10.1007/s11940-018-0490-9.

Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland. (2018) Winter, J. R., H. R. Stagg, C. J. Smith, M. K. Lalor, J. A. Davidson, A. E. Brown, J. Brown, D. Zenner, M. Lipman, A. Pozniak, I. Abubakar and V. Delpech. BMC Med 16(1): 85 https://doi.org/10.1186/s12916-018-1070-2.

Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes. (2018) Collin, S. M., G. de Vries, K. Lonnroth, G. B. Migliori, I. Abubakar, S. R. Anderson and D. Zenner. Eur Respir J 52(6) https://doi.org/10.1183/13993003.01449-2018.

Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence. (2018) Winter, J. R., A. L. Adamu, R. K. Gupta, H. R. Stagg, V. Delpech and I. Abubakar. Int J Tuberc Lung Dis 22(7): 713-722 https://doi.org/10.5588/ijtld.17.0672.

Tuberculosis research and development: seeding the future. (2018) Lienhardt, C., A. Zumla, N. Gebreselassie, M. Frick, G. Gray, T. Kasaeva and M. Raviglione. Lancet Respir Med 6(4): 242-244 https://doi.org/10.1016/S2213-2600(18)30050-X.

Tuberculosis series. (2018) Silva, D. R., F. C. Q. Mello, A. Kritski, M. Dalcolmo, A. Zumla and G. B. Migliori. J Bras Pneumol 44(2): 71-72 https://doi.org/10.1590/s1806-37562018000020001.

Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. (2018) Walzl, G., R. McNerney, N. du Plessis, M. Bates, T. D. McHugh, N. N. Chegou and A. Zumla. Lancet Infect Dis 18(7): e199-e210 https://doi.org/10.1016/S1473-3099(18)30111-7.

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. (2018) Tiberi, S., N. du Plessis, G. Walzl, M. J. Vjecha, M. Rao, F. Ntoumi, S. Mfinanga, N. Kapata, P. Mwaba, T. D. McHugh, G. Ippolito, G. B. Migliori, M. J. Maeurer and A. Zumla. Lancet Infect Dis 18(7): e183-e198 https://doi.org/10.1016/S1473-3099(18)30110-5.

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study. (2018) Abubakar, I., A. Lalvani, J. Southern, A. Sitch, C. Jackson, O. Onyimadu, M. Lipman, J. J. Deeks, C. Griffiths, G. Bothamley, O. M. Kon, A. Hayward, J. Lord and F. Drobniewski. Health Technol Assess 22(56): 1-96 https://doi.org/10.3310/hta22560.

Understanding tuberculosis transmission in the United Kingdom: findings from 6 years of mycobacterial interspersed repetitive unit-variable number tandem repeats strain typing, 2010-2015. (2018) Davidson, J. A., H. L. Thomas, H. Maguire, T. Brown, A. Burkitt, N. Macdonald, C. N. J. Campbell and M. K. Lalor. Am J Epidemiol 187(10): 2233-2242 https://doi.org/10.1093/aje/kwy119.

The unexpected essentiality of glna2 in Mycobacterium smegmatis is salvaged by overexpression of the global nitrogen regulator glnr, but not by l-, d- or iso-glutamine. (2018) Rakovitsky, N., M. Bar Oz, K. Goldberg, S. Gibbons, O. Zimhony and D. Barkan. Front Microbiol 9: 2143 https://doi.org/10.3389/fmicb.2018.02143.

Update in tuberculosis and nontuberculous mycobacteria 2017. (2018) Abubakar, I., R. K. Gupta, M. X. Rangaka and M. Lipman. Am J Respir Crit Care Med 197(10): 1248-1253 https://doi.org/10.1164/rccm.201801-0106UP.

The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak. (2018) Lalor, M. K., N. Casali, T. M. Walker, L. F. Anderson, J. A. Davidson, N. Ratna, C. Mullarkey, M. Gent, K. Foster, T. Brown, J. Magee, A. Barrett, D. W. Crook, F. Drobniewski, H. L. Thomas and I. Abubakar. Eur Respir J 51(6) https://doi.org/10.1183/13993003.02313-2017.

Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe. (2018) Villanueva, P., O. Neth, N. Ritz, M. Tebruegge and G. Paediatric Tuberculosis Network European Trials. Eur Respir J 51(5) https://doi.org/10.1183/13993003.00346-2018.

Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. (2018) Gunasekeran, D. V., B. Gupta, J. Cardoso, C. E. Pavesio and R. Agrawal. Ocul Immunol Inflamm 26(6): 865-869 https://doi.org/10.1080/09273948.2017.1296580.

A wake-promoting circadian output circuit in Drosophila. (2018) Lamaze, A., P. Kratschmer, K. F. Chen, S. Lowe and J. E. C. Jepson. Curr Biol 28(19): 3098-3105 e3093 https://doi.org/10.1016/j.cub.2018.07.024.

When do coinfections matter? (2018) McArdle, A. J., A. Turkova and A. J. Cunnington. Curr Opin Infect Dis https://doi.org/10.1097/QCO.0000000000000447.

World TB Day 2018: The challenge of drug resistant tuberculosis. (2018) Gupta-Wright, A., G. S. Tomlinson, M. X. Rangaka and H. A. Fletcher. F1000Res 7: 217 https://doi.org/10.12688/f1000research.14088.1.